Table 4 Comparison of the descriptive characteristics of patients who were prescribed BZDs (n = 6,405) according to age (less than 65/65 or more)
From: Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study
Patients 18+ | < 65 (n = 4,667) | ≥ 65 (n = 1,738) | P value |
|---|---|---|---|
Mean age (SD) | 45.2 (11.5) | 75.5 (6.9) | P < 0.001 |
% female | 62.7 | 67.8 | P < 0.001 |
Nb consultations/patient/year (SD) | 5.15 (3.4) | 5.98 (3.1) | P < 0.001 |
Nb consultations/patient/year with at least one prescription (SD) | 4.4 (2.9) | 5.0 (2.7) | P < 0.001 |
% patients with > 4 consultations/year | 50.0 | 63.9 | P < 0.001 |
% patients | |||
- with anxiety | 17.8 | 14.5 | p = 0.002 |
- with depression | 46.8 | 26.7 | P < 0.001 |
- with insomnia | 17.8 | 29.2 | P < 0.001 |
- with cardiovascular diseases | 24,9 | 67.3 | P < 0.001 |
- with arthropathic diseases | 23.2 | 39.8 | P < 0.001 |
Mean nb of BZDs prescriptions/year (SD) | 2.4 (2.3) | 3.3 (2.3) | P < 0.001 |
% patients with at least one prescription of | |||
- N05BA | 75.6 | 66.9 | P < 0.001 |
- N05CD | 5.3 | 6.3 | NS |
- N03AE | 8.1 | 10.9 | P < 0.001 |
- N05CF | 25.9 | 27.6 | NS |